Covalon Technologies Ltd
XTSX:COV
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.96
3.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one COV stock under the Base Case scenario is 1.64 CAD. Compared to the current market price of 3.63 CAD, Covalon Technologies Ltd is Overvalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Covalon Technologies Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for COV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Covalon Technologies Ltd
Balance Sheet Decomposition
Covalon Technologies Ltd
Current Assets | 23.3m |
Cash & Short-Term Investments | 9.4m |
Receivables | 6.3m |
Other Current Assets | 7.5m |
Non-Current Assets | 3.3m |
PP&E | 1.4m |
Intangibles | 1.5m |
Other Non-Current Assets | 458.6k |
Current Liabilities | 4.4m |
Accounts Payable | 3.8m |
Other Current Liabilities | 669.8k |
Non-Current Liabilities | 417.2k |
Long-Term Debt | 412.7k |
Other Non-Current Liabilities | 4.5k |
Earnings Waterfall
Covalon Technologies Ltd
Revenue
|
29.2m
CAD
|
Cost of Revenue
|
-12.7m
CAD
|
Gross Profit
|
16.5m
CAD
|
Operating Expenses
|
-17.9m
CAD
|
Operating Income
|
-1.4m
CAD
|
Other Expenses
|
553.2k
CAD
|
Net Income
|
-823.4k
CAD
|
Free Cash Flow Analysis
Covalon Technologies Ltd
CAD | |
Free Cash Flow | CAD |
Covalon reported a significant turnaround in its Q3 financials, achieving a 47% revenue growth to $9.2 million and a gross margin of 59%. Adjusted EBITDA improved by $2.8 million, reaching $2.4 million from a $400,000 loss the previous year. Earnings per share grew to $0.06 from a $0.02 loss. The U.S. market drove most of the success, representing 87% of total revenue, with a notable increase in product revenue by 52.6%. The company's strategic cost management reduced operating expenses by $236,000, leading to overall profitability. Covalon aims for continued growth in Q4 and beyond, focusing heavily on the U.S. market and operational efficiency.
What is Earnings Call?
COV Profitability Score
Profitability Due Diligence
Covalon Technologies Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Covalon Technologies Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
COV Solvency Score
Solvency Due Diligence
Covalon Technologies Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Covalon Technologies Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COV Price Targets Summary
Covalon Technologies Ltd
Dividends
Current shareholder yield for COV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.
Contact
IPO
Employees
Officers
The intrinsic value of one COV stock under the Base Case scenario is 1.64 CAD.
Compared to the current market price of 3.63 CAD, Covalon Technologies Ltd is Overvalued by 55%.